Ardsley Advisory Partners LP Albireo Pharma, Inc. Transaction History

Ardsley Advisory Partners LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$30.67 - $37.86 $233,092 - $287,736	-7,600 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$22.22 - $32.21 $55,550 - $80,525	-2,500 Reduced 24.75%	7,600 $245,000
Q3 2018 Nov 14, 2018	SELL	$29.29 - $36.87 $146,450 - $184,350	-5,000 Reduced 33.11%	10,100 $333,000
Q2 2018 Aug 14, 2018	SELL	$28.9 - $37.31 $28,900 - $37,310	-1,000 Reduced 6.21%	15,100 $536,000
Q1 2018 May 15, 2018	BUY	$26.78 - $39.35 $128,544 - $188,880	4,800 Added 42.48%	16,100 $535,000
Q4 2017 Feb 14, 2018	BUY	$21.56 - $28.14 $243,628 - $317,982	11,300	11,300 $289,000

865

Ticker ALBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 19,612,500
Description
Albireo Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver or gastrointestinal diseases and disorders. The company offers Bylvay for the treatment of progressive familial intrahepatic cholestasis, as we...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.